Hap Trading, LLC Biocryst Pharmaceuticals Inc Transaction History

Hap Trading, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$10.79 - $14.81 $43,408 - $59,580	-4,023 Reduced 18.41%	17,834 $225,000
Q2 2022 Aug 12, 2022	SELL	$7.89 - $17.88 $104,771 - $237,428	-13,279 Reduced 37.79%	21,857 $231,000
Q1 2022 May 12, 2022	SELL	$11.56 - $19.76 $700,998 - $1.2 Million	-60,640 Reduced 63.31%	35,136 $571,000
Q4 2021 Feb 14, 2022	BUY	$11.18 - $15.46 $246,217 - $340,475	22,023 Added 29.86%	95,776 $1.33 Million
Q3 2021 Nov 10, 2021	BUY	$14.21 - $17.65 $803,518 - $998,036	56,546 Added 328.62%	73,753 $1.06 Million
Q2 2021 Aug 11, 2021	BUY	$9.5 - $17.24 $163,466 - $296,648	17,207 New	17,207 $272,000

278

171M

625K

739K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.47B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.